{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:35:32Z","timestamp":1768620932465,"version":"3.49.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ejphar.2020.172959","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T19:40:56Z","timestamp":1580240456000},"page":"172959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Infliximab ameliorates tumor necrosis factor-alpha exacerbated renal insulin resistance induced in rats by regulating insulin signaling pathway"],"prefix":"10.1016","volume":"872","author":[{"given":"Hoda E.","family":"Mohamad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mervat E.","family":"Asker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed M.","family":"Keshawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara M.","family":"Abdel Aal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin K.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.172959_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jcb.26174","article-title":"Tumor necrosis factor\u2010alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus","volume":"119","author":"Akash","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2020.172959_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cbi.2011.03.014","article-title":"Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression","volume":"192","author":"Alhaider","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2020.172959_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1756-185X.12202","article-title":"(Dose optimization of infliximab in patients with rheumatoid arthritis","volume":"17","author":"Alten","year":"2014","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.ejphar.2020.172959_bib4","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1210\/en.2007-0132","article-title":"Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes","volume":"148","author":"Araujo","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2020.172959_bib5","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.cmi.2017.12.025","volume":"24","author":"Baddley","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejphar.2020.172959_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1677\/JOE-07-0234","article-title":"Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet","volume":"194","author":"Barbuio","year":"2007","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2020.172959_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2310\/JIM.0b013e3182746f95","article-title":"Insulin signaling and insulin resistance","volume":"61","author":"Beale","year":"2013","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.ejphar.2020.172959_bib8","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.24001","article-title":"Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two\u2010year period","volume":"59","author":"Braun","year":"2008","journal-title":"Arthritis Care Res.: Off. J. Am. Coll. Rheumatol."},{"key":"10.1016\/j.ejphar.2020.172959_bib9","doi-asserted-by":"crossref","first-page":"e0128889","DOI":"10.1371\/journal.pone.0128889","article-title":"Effects of tumour necrosis factor antagonists on insulin sensitivity\/resistance in rheumatoid arthritis: a systematic review and meta-analysis","volume":"10","author":"Burska","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.172959_bib10","first-page":"1274","article-title":"Insulin resistance and vascular dysfunction in chronic kidney disease: mechanisms and therapeutic interventions","volume":"32","author":"Chan","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2020.172959_bib80","first-page":"953","article-title":"Effect of infliximab against cisplatin-induced nephrotoxicity","volume":"35","author":"Cure","year":"2014","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.ejphar.2020.172959_bib11","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1073\/pnas.1215840110","article-title":"B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile","volume":"110","author":"DeFuria","year":"2013","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejphar.2020.172959_bib12","doi-asserted-by":"crossref","first-page":"E685","DOI":"10.1152\/ajpendo.00283.2010","article-title":"A highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome","volume":"299","author":"Dekker","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2020.172959_bib13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ncpendmet0894","article-title":"The pathogenesis of diabetic nephropathy","volume":"4","author":"Dronavalli","year":"2008","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejphar.2020.172959_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1155\/2016\/3140290","article-title":"Lycium barbarum polysaccharide mediated the antidiabetic and antinephritic effects in diet-streptozotocin-induced diabetic Sprague Dawley rats via regulation of NF-\u03baB","volume":"2016","author":"Du","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejphar.2020.172959_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jnutbio.2013.11.010","article-title":"Betaine supplementation protects against high-fructose-induced renal injury in rats","volume":"25","author":"Fan","year":"2014","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ejphar.2020.172959_bib16","series-title":"The Kidney and Hypertension in Diabetes Mellitus","first-page":"141","article-title":"Effects of insulin on the kidney and the cardiovascular system","author":"Ferrannini","year":"2000"},{"key":"10.1016\/j.ejphar.2020.172959_bib17","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.cgh.2016.05.044","article-title":"Discontinuation of infliximab in patients with ulcerative colitis is associated with increased risk of relapse: a multinational retrospective cohort study","volume":"14","author":"Fiorino","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2020.172959_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2020.172959_bib19","doi-asserted-by":"crossref","first-page":"F1256","DOI":"10.1152\/ajprenal.00181.2007","article-title":"Fructose, but not dextrose, accelerates the progression of chronic kidney disease","volume":"293","author":"Gersch","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2020.172959_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ncpendmet0046","article-title":"Mechanisms of disease: pathway-selective insulin resistance and microvascular complications of diabetes","volume":"1","author":"Groop","year":"2005","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejphar.2020.172959_bib21","first-page":"214","article-title":"Molecular mechanisms of insulin resistance: an update","volume":"153","author":"Guti\u00e9rrez-Rodelo","year":"2017","journal-title":"Gac. Med. Mex."},{"key":"10.1016\/j.ejphar.2020.172959_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/fcp.12231","article-title":"Geniposide reduces development of streptozotocin\u2010induced diabetic nephropathy via regulating nuclear factor\u2010kappa B signaling pathways","volume":"31","author":"Hu","year":"2017","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172959_bib23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1139\/cjpp-2016-0152","article-title":"Curcumin improves the metabolic syndrome in high-fructose-diet-fed rats: role of TNF-\u03b1, NF-\u03baB, and oxidative stress","volume":"95","author":"Kelany","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172959_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/1179551418792257","article-title":"Montan PD, Guzman E (The impact of insulin resistance and chronic kidney disease on inflammation and cardiovascular disease","volume":"11","author":"Kosmas","year":"2018","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"key":"10.1016\/j.ejphar.2020.172959_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm0106-43","article-title":"The humoral side of insulin resistance","volume":"12","author":"Lazar","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2020.172959_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1748-1716.2007.01782.x","article-title":"SOCS proteins causing trouble in insulin action","volume":"192","author":"Lebrun","year":"2008","journal-title":"Acta Physiol."},{"key":"10.1016\/j.ejphar.2020.172959_bib27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/ecco-jcc\/jjw053","article-title":"Mechanism of action of anti-TNF therapy in inflammatory bowel disease","volume":"10","author":"Levin","year":"2016","journal-title":"J. Crohn's Colitis"},{"key":"10.1016\/j.ejphar.2020.172959_bib28","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1440-1681.2011.05602.x","article-title":"Adipokines in inflammation, insulin resistance and cardiovascular disease","volume":"38","author":"Li","year":"2011","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2020.172959_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.taap.2014.03.016","article-title":"Oleanolic acid supplement attenuates liquid fructose-induced adipose tissue insulin resistance through the insulin receptor substrate-1\/phosphatidylinositol 3-kinase\/Akt signaling pathway in rats","volume":"277","author":"Li","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172959_bib30","first-page":"12","article-title":"Insulin resistance in patients with chronic kidney disease","volume":"2012","author":"Liao","year":"2012","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejphar.2020.172959_bib31","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jfda.2016.06.005","article-title":"Long-term feeding of red algae (Gelidium amansii) ameliorates glucose and lipid metabolism in a high fructose diet-impaired glucose tolerance rat model","volume":"25","author":"Liu","year":"2017","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.ejphar.2020.172959_bib32","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"Cantley LC (AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2020.172959_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12716","article-title":"(Infliximab ameliorates tumor necrosis factor\u2010alpha\u2010induced insulin resistance by attenuating PTP 1B activation in 3T3L1 adipocytes in vitro","volume":"88","author":"M\u00e9ndez\u2010Garc\u00eda","year":"2018","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ejphar.2020.172959_bib34","first-page":"850","article-title":"TNF-alpha antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients","volume":"30","author":"Miranda-Filloy","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.ejphar.2020.172959_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cca.2006.07.005","article-title":"Molecular mechanisms of insulin resistance and associated diseases","volume":"375","author":"Mlinar","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2020.172959_bib36","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s11745-010-3475-3","article-title":"Dietary monounsaturated fatty acids but not saturated fatty acids preserve the insulin signaling pathway via IRS\u20101\/PI3K in rat skeletal muscle","volume":"45","author":"Moon","year":"2010","journal-title":"Lipids"},{"key":"10.1016\/j.ejphar.2020.172959_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/14740338.2019.1577817","article-title":"Update upon the infection risk in patients receiving TNF alpha inhibitors","volume":"18","author":"Murdaca","year":"2019","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ejphar.2020.172959_bib81","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/TP.0000000000001222","article-title":"Anti-TNF-\u03b1 agent infliximab and splenectomy are protective against renal ischemia-reperfusion injury","volume":"100","author":"Nagata","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.ejphar.2020.172959_bib38","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double\u2010blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2020.172959_bib39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jbspin.2016.09.001","article-title":"Rheumatoid arthritis, insulin resistance, and diabetes","volume":"84","author":"Nicolau","year":"2017","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ejphar.2020.172959_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2017.03.042","article-title":"Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: molecular and pharmacological insights","volume":"803","author":"Nyane","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172959_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094228","article-title":"Garlic attenuates cardiac oxidative stress via activation of PI3K\/AKT\/Nrf2-Keap1 pathway in fructose-fed diabetic rat","volume":"9","author":"Padiya","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.172959_bib42","first-page":"275","article-title":"The therapy of insulin resistance in other diseases besides type 2 diabetes. Eating and Weight Disorders-Studies on Anorexia","volume":"19","author":"Pala","year":"2014","journal-title":"Bulimia Obes."},{"key":"10.1016\/j.ejphar.2020.172959_bib43","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00592-017-1027-5","article-title":"Metformin attenuates the TLR4 inflammatory pathway in skeletal muscle of diabetic rats","volume":"54","author":"Peixoto","year":"2017","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ejphar.2020.172959_bib44","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/MNH.0b013e32834b23c1","article-title":"Measurement of insulin resistance in chronic kidney disease","volume":"20","author":"Pham","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ejphar.2020.172959_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2008.07.013","article-title":"Increased expression of SOCS3 in monocytes and SOCS1 in lymphocytes correlates with progressive loss of renal function and cardiovascular risk factors in chronic kidney disease","volume":"593","author":"Rastmanesh","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172959_bib46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2008.11.014","article-title":"Increased SOCS expression in peripheral blood mononuclear cells of end stage renal disease patients is related to inflammation and dialysis modality","volume":"602","author":"Rastmanesh","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172959_bib47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12929-016-0303-y","article-title":"Akash MSH (Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?","volume":"23","author":"Rehman","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejphar.2020.172959_bib48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5603\/EP.2017.0026","article-title":"(Insulin resistance in endocrine disorders\u2014treatment options","volume":"68","author":"Rogowicz-Frontczak","year":"2017","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.ejphar.2020.172959_bib49","first-page":"127","article-title":"Insulin resistance in end stage renal disease (ESRD) patients in Eastern India: a population based observational study","volume":"4","author":"Roy","year":"2014","journal-title":"J. Drug Deliv. Therapeut."},{"key":"10.1016\/j.ejphar.2020.172959_bib50","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.pharep.2016.07.010","article-title":"Animal models of insulin resistance: a review","volume":"68","author":"Sah","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2020.172959_bib51","doi-asserted-by":"crossref","first-page":"F423","DOI":"10.1152\/ajprenal.00124.2006","article-title":"Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats","volume":"292","author":"S\u00e1nchez-Lozada","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2020.172959_bib52","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cbi.2015.09.002","article-title":"NFAT inhibitor tributylhexadecylphosphoniumbromide, ameliorates high fructose induced insulin resistance and nephropathy","volume":"240","author":"Sanghavi","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2020.172959_bib53","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.etap.2015.01.002","article-title":"Atmaca HT (Tnf-\u03b1 inhibition by infliximab as a new target for the prevention of glycerol-contrast-induced nephropathy","volume":"39","author":"Saritemur","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172959_bib54","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12882-019-1220-6","article-title":"Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study","volume":"20","author":"Schrauben","year":"2019","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.ejphar.2020.172959_bib55","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12291-017-0647-4","article-title":"Homeostatic model assessment-insulin resistance (HOMA-IR 2) in mild subclinical hypothyroid subjects","volume":"33","author":"Sengupta","year":"2018","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.ejphar.2020.172959_bib56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.exger.2017.09.011","article-title":"Assessment of fructose overload in the metabolic profile and oxidative\/nitrosative stress in the kidney of senescent female rats","volume":"99","author":"Seraphim","year":"2017","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ejphar.2020.172959_bib57","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20050216","article-title":"Grb10 and Grb14: enigmatic regulators of insulin action\u2013and more?","volume":"388","author":"Siddle","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2020.172959_bib58","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4239\/wjd.v1.i2.36","article-title":"Surrogate markers of insulin resistance: a review","volume":"1","author":"Singh","year":"2010","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.ejphar.2020.172959_bib59","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12558","article-title":"TLR 4 mutant mice are protected from renal fibrosis and chronic kidney disease progression","volume":"3","author":"Souza","year":"2015","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.ejphar.2020.172959_bib60","doi-asserted-by":"crossref","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","article-title":"Insulin resistance in chronic kidney disease: a systematic review","volume":"311","author":"Spoto","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2020.172959_bib61","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1186\/ar3824","article-title":"Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behcet's disease","volume":"14","author":"Sugita","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2020.172959_bib62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action","volume":"7","author":"Taniguchi","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2020.172959_bib63","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.jrn.2014.10.019","article-title":"Insulin resistance as a therapeutic target for chronic kidney disease","volume":"25","author":"Teta","year":"2015","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.ejphar.2020.172959_bib64","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/ki.2015.305","article-title":"Molecular mechanisms of insulin resistance in chronic kidney disease","volume":"88","author":"Thomas","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2020.172959_bib65","doi-asserted-by":"crossref","first-page":"21848","DOI":"10.1074\/jbc.C116.732990","article-title":"Metformin improves metabolic memory in high fat diet (HFD)-induced renal dysfunction","volume":"291","author":"Tikoo","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.172959_bib66","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jnutbio.2013.04.001","article-title":"Enhanced prereceptor glucocorticoid metabolism and lipogenesis impair insulin signaling in the liver of fructose-fed rats","volume":"24","author":"Vasiljevi\u0107","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ejphar.2020.172959_bib67","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/hep.22523","article-title":"Suppressor of cytokine signaling\u20103 (SOCS\u20103) and a deficit of serine\/threonine (Ser\/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism","volume":"48","author":"Vil\u00e0","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2020.172959_bib68","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.taap.2010.11.011","article-title":"Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment","volume":"251","author":"Vil\u00e0","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172959_bib69","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2020.172959_bib70","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2020.172959_bib71","first-page":"4661","article-title":"Expression of the Wnt\/\u03b2-catenin signal pathway in patients with acute renal injury","volume":"21","author":"Wang","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2020.172959_bib72","first-page":"2413","article-title":"Valsartan alleviates insulin resistance in skeletal muscle of chronic renal failure rats","volume":"24","author":"Wang","year":"2018","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res.: Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.ejphar.2020.172959_bib73","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000479801","article-title":"Insulin resistance in kidney disease: is there a distinct role separate from that of diabetes or obesity","volume":"8","author":"Whaley-Connell","year":"2018","journal-title":"Cardiorenal Med."},{"key":"10.1016\/j.ejphar.2020.172959_bib74","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1530\/JOE-15-0409","article-title":"Metformin improves hepatic IRS2\/PI3K\/Akt signaling in insulin-resistant rats of NASH and cirrhosis","volume":"229","author":"Xu","year":"2016","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2020.172959_bib75","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1002\/jcp.27603","article-title":"Insulin resistance: review of the underlying molecular mechanisms","volume":"234","author":"Yaribeygi","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2020.172959_bib76","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1521-690X(03)00033-2","article-title":"(Insulin resistance and endothelial dysfunction","volume":"17","author":"Yki-J\u00e4rvinen","year":"2003","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2020.172959_bib77","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12079-013-0210-x","article-title":"Grape seed proanthocyanidins and metformin act by different mechanisms to promote insulin signaling in rats fed high calorie diet","volume":"8","author":"Yogalakshmi","year":"2014","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.ejphar.2020.172959_bib78","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.metabol.2013.05.020","article-title":"Acute effects of fructose consumption on uric acid and plasma lipids in patients with impaired renal function","volume":"62","author":"Zawiasa","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2020.172959_bib79","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1155\/2016\/4847812","article-title":"Metformin inhibits advanced glycation end products-induced inflammatory response in murine macrophages partly through AMPK activation and RAGE\/NF\u03baB pathway suppression","volume":"2016","author":"Zhou","year":"2016","journal-title":"J. Diabetes Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920300510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920300510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:34:15Z","timestamp":1757975655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920300510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":81,"alternative-id":["S0014299920300510"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.172959","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infliximab ameliorates tumor necrosis factor-alpha exacerbated renal insulin resistance induced in rats by regulating insulin signaling pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.172959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172959"}}